STATE STREET CORP - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 53 filers reported holding DESIGN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,634,826
-55.7%
692,723
+18.2%
0.00%
Q2 2023$3,692,021
-10.1%
586,035
-17.6%
0.00%
Q1 2023$4,105,517
-93.4%
711,528
-88.3%
0.00%
-100.0%
Q4 2022$62,328,680
+309.9%
6,074,920
+568.0%
0.00%
+100.0%
Q3 2022$15,206,000
+141.5%
909,469
+102.2%
0.00%
Q2 2022$6,297,000
-3.4%
449,781
+11.5%
0.00%
Q1 2022$6,517,000
-11.1%
403,541
+17.9%
0.00%
Q4 2021$7,328,000
+135.7%
342,261
+61.7%
0.00%
Q3 2021$3,109,000
-16.9%
211,608
+12.5%
0.00%
Q2 2021$3,741,000188,0890.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders